Close

ChemoCentryx (CCXI) Announces Significant Data from CCX872 In Vivo Models of NASH

October 18, 2016 8:32 AM EDT Send to a Friend
ChemoCentryx, Inc., (Nasdaq: CCXI) announced the presentation of data from in vivo models of non-alcoholic steatohepatitis (NASH) with CCX872, a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login